BIOVENTIX PLC Logo

BIOVENTIX PLC

Develops and supplies sheep monoclonal antibodies for clinical diagnostic platforms.

BVXP | IL

Overview

Corporate Details

ISIN(s):
GB00B4QVDF07
LEI:
213800225MHX7LZQY108
Country:
United Kingdom
Address:
7 ROMANS BUSINESS PARK, GU9 7SX FARNHAM

Description

Bioventix PLC is a biotechnology company that specializes in the development, creation, and commercial supply of high-affinity sheep monoclonal antibodies (SMAs). These antibodies are utilized by global diagnostic companies as critical components in clinical diagnostic platforms, particularly for blood testing immunoassays. The company's portfolio supports a variety of applications, including diagnostics for cardiovascular conditions (troponin), oncology, and neurodegenerative diseases such as Alzheimer's. In addition to its core antibody products, Bioventix also provides ELISA kits for monitoring exposure to industrial pollutants and offers contract services for the development of new SMAs for healthcare organizations.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-10-28 08:00
Results for the year ended 30 June 2024
English 442.9 KB
2024-10-25 11:37
Holding(s) in Company
English 31.1 KB
2024-10-16 14:51
Holding(s) in Company
English 43.9 KB
2024-04-30 08:00
Director/PDMR Shareholding
English 19.2 KB
2024-04-12 12:05
Holding(s) in Company
English 53.7 KB
2024-03-25 08:00
Interim Results
English 144.5 KB
2024-01-29 16:15
Director/PDMR Shareholding
English 17.6 KB
2023-12-07 16:26
Result of AGM
English 7.7 KB
2023-11-28 16:26
Director/PDMR Shareholding
English 18.9 KB
2023-11-16 13:40
Holding(s) in Company
English 52.2 KB
2023-11-10 17:23
Posting of Annual Report and Notice of AGM
English 8.8 KB
2023-11-07 13:07
Holding(s) in Company
English 66.2 KB
2023-11-01 17:07
Holding(s) in Company
English 65.6 KB
2023-10-30 08:00
Results for the year ended 30 June 2023
English 344.4 KB
2023-09-25 17:28
Holding(s) in Company
English 23.9 KB

Automate Your Workflow. Get a real-time feed of all BIOVENTIX PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BIOVENTIX PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BIOVENTIX PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.